Posted on 8/6/20
Bristol Myers Squibb Reports Second Quarter 2020 Financial Results
NEW YORK--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE:BMY) today reports results for the second quarter of 2020, which reflect strong product sales, continued advancement of the pipeline and . . .
Posted on 8/6/20
Provention Bio Reports Second Quarter 2020 Financial Results and Provides Business Update
Provention Bio, Inc. (Nasdaq: PRVB), a clinical-stage biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today reported financial results for the second quarter ended June . . .
Posted on 8/6/20
Amneal Reports Second Quarter 2020 Financial Results
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (NYSE: AMRX) announced its results today for the second quarter ended June 30, 2020.“Amneal executed well against our operational and strategic goals . . .
Posted on 8/6/20
Concord Health Partners Announces Investment in Cedar's Series C Funding
Concord Health Partners, a healthcare focused investment firm, announced today its investment in the Series C funding of Cedar, a leading patient engagement and financial technology . . .
Posted on 8/6/20
Pacira BioSciences Reports Second Quarter 2020 Financial Results and Business Update
PARSIPPANY, N.J., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), a leading provider of innovative non-opioid pain management options, today reported financial results . . .
Posted on 8/6/20
BioLineRx Reports Second Quarter 2020 Financial Results and Provides Corporate Update
BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a late clinical-stage biopharmaceutical company focused on oncology, today reports its financial results for the quarter ended June 30, 2020 . . .
Posted on 8/6/20
MeiraGTx Reports Second Quarter 2020 Financial Results
LONDON and NEW YORK, Aug. 06, 2020 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today announced financial . . .
Posted on 8/6/20
CipherHealth Accelerates Growth with Financing from CIBC Innovation Banking
CIBC Innovation Banking is pleased to announce growth capital financing for CipherHealth, an industry leader in healthcare technology solutions for patient engagement and communication.
Posted on 8/6/20
22nd Century Group Reports Financial Results and Business Highlights for the Second Quarter 2020
WILLIAMSVILLE, N.Y., Aug. 06, 2020 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant biotechnology company focused on technologies that alter the . . .
Posted on 8/6/20
Teladoc Health Merging with Livongo Health in Deal Worth $18.5 Billion
The virtual care field got a little smaller on Wednesday morning. Teladoc Health (NYSE:TDOC) will acquire
Posted on 8/5/20
OPEN MINDS & NextGen Healthcare Form Platinum Partnership
OPEN MINDS announced NextGen Healthcare, Inc. (Nasdaq: NXGN) has become an OPEN MINDS Platinum Partner. NextGen Healthcare, a leading provider of ambulatory-focused technology solutions, continues to . . .
Posted on 8/5/20
Citius Pharmaceuticals Announces $6M Bought Deal Offering
Citius Pharmaceuticals, Inc. (Nasdaq: CTXR), a specialty pharmaceutical company focused on developing and commercializing critical care drug products, announced today that it has entered into an underwriting . . .
Posted on 8/5/20
Immunic Announces Pricing of $90.0 Million Public Offering of Common Stock
Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, today announced . . .
Posted on 8/5/20
Genesis Biotechnology Group Acquires Comparative Biosciences
Genesis Drug Discovery & Development (GD3), a member of Genesis Biotechnology Group (GBG) announced today that it has acquired Comparative Biosciences, Inc. (CBI), a Contract Research . . .
Posted on 8/5/20
Regeneron Reports Second Quarter 2020 Financial and Operating Results
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced financial results for the second quarter of 2020 and provided a business update."I'm very proud of how the Regeneron . . .
Posted on 8/5/20
Oyster Point Pharma Reports Second Quarter 2020 Financial Results and Recent Business Highlights
PRINCETON, N.J., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Oyster Point Pharma, Inc. (Nasdaq: OYST), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of . . .
Posted on 8/5/20
Teladoc Health and Livongo Merge
Teladoc Health (TDOC), the global leader in virtual care, and Livongo (LVGO), the leading Applied Health Signals company – today announced that they have entered into . . .
Posted on 8/5/20
Merck Animal Health Completes Acquisition of IdentiGEN
MADISON, N.J.--(BUSINESS WIRE)--Merck Animal Health, known as MSD Animal Health outside the United States and Canada, a division of Merck & Co., Inc., Kenilworth, N.J., USA . . .
Posted on 8/5/20
Will Moderna Get Away With Charging 50% More Than Pfizer for Its Coronavirus Vaccine?
We now have a pretty good idea how much COVID-19 vaccines will cost Uncle Sam. Last week, The U.S. government announced a deal with Pfizer (NYSE:PFE) . . .
Posted on 8/4/20
Merck and Hanmi Pharmaceutical Enter into Licensing Agreement
KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Hanmi Pharmaceutical today announced that the companies have entered into an . . .
Posted on 8/4/20
Ivy Rehab Joins UnitedHealthcare and Oxford Health Plans as In-Network Provider in New York
Ivy Rehab Physical Therapy, a national leader in outpatient physical, occupational, and speech therapy services, has joined the UnitedHealthcare and Oxford Health Plans network in New . . .
Posted on 8/4/20
Quartet Health Partners With SilverCloud Health
NEW YORK--(BUSINESS WIRE)--Today, Quartet Health announced a partnership with SilverCloud Health to offer clinically-validated digital mental health support to its patients nationwide. Through the collaboration, patients . . .
Posted on 8/4/20
Cytovia Therapeutics Acquires Worldwide Rights to CytoImmune Therapeutics
NEW YORK and MONROVIA, Calif., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Cytovia Therapeutics, Inc, an emerging biopharmaceutical company developing natural killer (NK) immunotherapies for cancer, today . . .
Posted on 8/4/20
RespireRx Pharmaceuticals Announces $2 Million Funding Commitment
RespireRx Pharmaceuticals Inc. (OTCQB: RSPI), has historically been and remains a leader in the research and development of ampakines for a variety of central nervous system . . .
Posted on 8/4/20
Arvinas Reports Second Quarter 2020 Financial Results and Provides Corporate Update
NEW HAVEN, Conn., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biopharmaceutical company creating a new class of drugs based on targeted . . .
New York
